These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 18094404)
1. Targeting the cell death-survival equation. Benz EJ; Nathan DG; Amaravadi RK; Danial NN Clin Cancer Res; 2007 Dec; 13(24):7250-3. PubMed ID: 18094404 [No Abstract] [Full Text] [Related]
2. Cell death mechanisms: life in the balance. Hague A; Verkhratsky A Cell Death Differ; 2009 Mar; 16(3):512-4. PubMed ID: 19219056 [No Abstract] [Full Text] [Related]
5. The roles of therapy-induced autophagy and necrosis in cancer treatment. Amaravadi RK; Thompson CB Clin Cancer Res; 2007 Dec; 13(24):7271-9. PubMed ID: 18094407 [TBL] [Abstract][Full Text] [Related]
6. Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death. Bianchi ME Trends Cell Biol; 2004 Jun; 14(6):287-93. PubMed ID: 15183185 [No Abstract] [Full Text] [Related]
7. Cell-cycle control in the face of damage--a matter of life or death. Clarke PR; Allan LA Trends Cell Biol; 2009 Mar; 19(3):89-98. PubMed ID: 19168356 [TBL] [Abstract][Full Text] [Related]
8. Apoptosis and non-apoptotic deaths in cancer development and treatment response. de Bruin EC; Medema JP Cancer Treat Rev; 2008 Dec; 34(8):737-49. PubMed ID: 18722718 [TBL] [Abstract][Full Text] [Related]
9. Targeting the DNA damage response in cancer. Ljungman M Chem Rev; 2009 Jul; 109(7):2929-50. PubMed ID: 19545147 [No Abstract] [Full Text] [Related]
11. Death on the slopes. Symposium on Cell Death Pathways. McPhee CK; Hill JH; Enoksson M EMBO Rep; 2009 Aug; 10(8):827-31. PubMed ID: 19609322 [No Abstract] [Full Text] [Related]
12. Is cell death a critical end point for anticancer therapies or is cytostasis sufficient? Rixe O; Fojo T Clin Cancer Res; 2007 Dec; 13(24):7280-7. PubMed ID: 18094408 [TBL] [Abstract][Full Text] [Related]
13. Triggers and signaling cross-talk controlling cell death commitment. Melo-Lima S; Gajate C; Mollinedo F Cell Cycle; 2015; 14(4):465-6. PubMed ID: 25590143 [No Abstract] [Full Text] [Related]
14. Farnesyl transferase inhibitors. Li T; Sparano JA Cancer Invest; 2008 Aug; 26(7):653-61. PubMed ID: 18665473 [No Abstract] [Full Text] [Related]
15. [Programmed cell death--significance for cancer etiology and treatment]. Smeland EB Tidsskr Nor Laegeforen; 1992 May; 112(12):1567. PubMed ID: 1615504 [No Abstract] [Full Text] [Related]
16. Purification and bioassay of hedgehog ligands for the study of cell death and survival. Martinez-Chinchilla P; Riobo NA Methods Enzymol; 2008; 446():189-204. PubMed ID: 18603123 [TBL] [Abstract][Full Text] [Related]
17. [Molecular targeting therapy for gynecologic cancer]. Hatae M; Nakamura T; Onishi Y; Yamamoto F Gan To Kagaku Ryoho; 2008 Feb; 35(2):233-237. PubMed ID: 18372513 [No Abstract] [Full Text] [Related]
18. Oncogenes in cell survival and cell death. Shortt J; Johnstone RW Cold Spring Harb Perspect Biol; 2012 Dec; 4(12):. PubMed ID: 23209150 [TBL] [Abstract][Full Text] [Related]
19. Targeting apoptosis as an approach for gastrointestinal cancer therapy. Qiao L; Wong BC Drug Resist Updat; 2009 Jun; 12(3):55-64. PubMed ID: 19278896 [TBL] [Abstract][Full Text] [Related]
20. Pien Tze Huang, a composite Chinese traditional herbal extract, affects survival of neuroblastoma cells. Lü L; Wai MS; Yew DT; Mak YT Int J Neurosci; 2009; 119(2):255-62. PubMed ID: 19125378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]